New Challenges for Clinicians and Chronic Pain Patients<sup>1</sup>

New Challenges for Clinicians and Chronic Pain Patients1

  • 84% of patients believe there is a stigma around opioid use
  • 42% admitted it has impacted how they communicate with their doctor about their pain
  • 90% of chronic pain patients are looking for new treatment option
Innovative Technology - 100% Drug Free

Innovative Technology - 100% Drug Free

Quell uses high frequency nerve stimulation to block pain signals. The free Quell Relief app1 is the control center of this revolutionary chronic pain relief system and offers unprecedented personalization and control of the therapy sessions.

Quell is up to 10x more powerful than typical OTC TENS devices2.

Designed to relieve chronic pain day and night

Quell has FDA 510(k) clearance for the symptomatic relieve and management of chronic intractable pain. It’s wearable technology may be used 24/7, so your patients can use the device during the day while active and at night while sleeping. Quell is 100% drug free and may be an option for your patients looking for a safe pain management technology with minimal side effects.

Quell, an innovative approach to pain relief

  • Available without prescription
  • No major side effects
  • Powered by the Quell Relief App which allows patients to personalize therapy and track usage, sleep, activity, gait and pain levels over time
  • Only OTC pain relief device FDA cleared for use while sleeping

How It Works

Quell uses prescription-strength nerve stimulation technology to block chronic pain. Quell is up to 10 times more powerful than typical OTC TENS devices2.

  1. Neurometrix/Vanson Bourne Research Survey of 1500 Chronic Pain Patients
  2. Comparison to leading OTC TENS devices, based on retail sales data. Maximum sustained energy when used as directed.
Benefits Quell® Technology OTC TENS Devices OTC Pain Meds[a] Other
Prescription Pain Meds[b]
Prescription
Opioid Pain Meds[c]
Treats Chronic Pain +/- +/-
24/7 Wearable Technology        
Nighttime Pain Relief  
No Major Side Effects      
No Addiction Potential +/-  
Smartphone Enabled +/-      
Digital Health Integration        
Available without Prescription    

Benefits

Treats Chronic Pain
24/7 Wearable Technology
Nighttime Pain Relief
No Major Side Effects
No Addiction Potential
Smartphone Enabled
Digital Health Integration
Available without Prescription
Treats Chronic Pain
24/7 Wearable Technology
 
Nighttime Pain Relief
 
No Major Side Effects
No Addiction Potential
Smartphone Enabled
Digital Health Integration
 
Available without Prescription
Treats Chronic Pain
24/7 Wearable Technology
 
Nighttime Pain Relief
No Major Side Effects
 
No Addiction Potential
Smartphone Enabled
 
Digital Health Integration
 
Available without Prescription
Treats Chronic Pain
24/7 Wearable Technology
 
Nighttime Pain Relief
No Major Side Effects
 
No Addiction Potential
Smartphone Enabled
 
Digital Health Integration
 
Available without Prescription
 
Treats Chronic Pain
24/7 Wearable Technology
 
Nighttime Pain Relief
No Major Side Effects
 
No Addiction Potential
 
Smartphone Enabled
 
Digital Health Integration
 
Available without Prescription
 
  1. Non-steroidal anti-inflammatory drugs, acetaminophen, aspirin, etc.
  2. Gabapentin, pregabalin, duloxetine, amitriptyline, etc.
  3. Hydrocodone, oxycodone, meperidine, etc.

Quell Research Studies

Selected posters and abstracts

Does the Anatomic Distribution of Chronic Pain Influence the Effectiveness of Fixed-Site High-Frequency Transcutaneous Electrical Nerve Stimulation?

Presented at American Academy of Pain Medicine 35thAnnual Meeting, March 6—9, 2019, Denver, CO, USA

Predictors of Chronic Pain Relief by Fixed-Site High-Frequency Transcutaneous Electrical Nerve Stimulation

Presented at American Academy of Pain Medicine 35thAnnual Meeting, March 6—9, 2019, Denver, CO, USA

Levels and Predictors of Activity in Users of Wearable Neurostimulators with Chronic Pain.

American Academy of Pain Medicine Annual Meeting, April 2018

Dose-Response of Surface Neurostimulation in Chronic Pain

American Pain Society Scientific Summit, March 2018

Pilot of Sleep/Wake Classification by Leg-Worn Actigraphy.

Abstract to American Academy of Neurology Annual Meeting, April 2018

Quell Band

Healthcare Professionals interested in dispensing Quell from their practice may contact NeuroMetrix at 1-800-204-6577 or our partner Meyer DC

Meyer DC

Sign me up for the latest news on Quell